EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A deep‐learning retinal aging biomarker for cognitive decline and incident dementia

Ming Ann Sim, Yih Chung Tham, Simon Nusinovici, Ten Cheer Quek, Marco Yu, Can Can Xue, Miao Li Chee, Qing Sheng Peng, Eugene S J Tan, Siew Pang Chan, Yuan Cai, Eddie Jun Yi Chong und 8 weitere

Alzheimer's & Dementia · 2025-03 · 21 (3)

DOI: 10.1002/alz.14601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.03.2025. Verfasst von Ming Ann Sim und 19 weiteren Autor:innen. Beteiligte Einrichtung: Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Dementia, Deep Learning, Aging. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National University Health System (NUHS) Clinician Scientist Academy, CSDU Collaborative Grant by the National University of Singapore Yong Loo Lin School of Medicine, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The utility of retinal photography‐derived aging biomarkers for predicting cognitive decline remains under‐explored. METHODS A memory‐clinic cohort in Singapore was followed‐up for 5 years. RetiPhenoAge, a retinal aging biomarker, was derived from retinal photographs using deep‐learning. Using competing risk analysis, we determined the associations of RetiPhenoAge with cognitive decline and dementia, with the UK Biobank utilized as the replication cohort. The associations of RetiPhenoAge with MRI markers(cerebral small vessel disease [CSVD] and neurodegeneration) and its underlying plasma proteomic profile were evaluated. RESULTS Of 510 memory‐clinic subjects( N = 155 cognitive decline), RetiPhenoAge associated with incident cognitive decline (subdistribution hazard ratio [SHR] 1.34, 95% confidence interval [CI] 1.10–1.64, p = 0.004), and incident dementia (SHR 1.43, 95% CI 1.02–2.01, p = 0.036). In the UK Biobank ( N = 33 495), RetiPhenoAge similarly predicted incident dementia (SHR 1.25, 95% CI 1.09–1.41, p = 0.008). RetiPhenoAge significantly associated with CSVD, brain atrophy, and plasma proteomic signatures related to aging. DISCUSSION RetiPhenoAge may provide a non‐invasive prognostic screening tool for cognitive decline and dementia. Highlights RetiPhenoAge, a retinal aging marker, was studied in an Asian memory clinic cohort. Older RetiPhenoAge predicted future cognitive decline and incident dementia. It also linked to neuropathological markers, and plasma proteomic profiles of aging. UK Biobank replication found that RetiPhenoAge predicted 12‐year incident dementia. Future studies should validate RetiPhenoAge as a prognostic biomarker for dementia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDementiaDeep LearningAgingRetinaHumansBiomarkersMaleFemaleAgedSingaporeMagnetic Resonance ImagingCohort StudiesIncidenceAged, 80 and over

Stichwörter der Autor:innen

Southeast‐Asianbiomarkercognitive declinedeep‐learningdementiaprognosticretinal ageretinal photography

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Memory Aging and Cognition Centre, Departments of Pharmacology and Psychological Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Anesthesia, National University Health System and National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.
  • Centre for Innovation and Precision Eye Health, and Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Ocular Epidemiology Research Group, Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
  • Ophthalmology and Visual Science Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.
  • National University Heart Centre, National University Hospital, Singapore, Singapore.

Förderung

  • National University Health System (NUHS) Clinician Scientist Academy
  • CSDU Collaborative Grant by the National University of Singapore Yong Loo Lin School of Medicine
  • National Medical Research Council

Zitieren

APA

Sim, M. A., Tham, Y. C., Nusinovici, S., Quek, T. C., Yu, M., Xue, C. C., Chee, M. L., Peng, Q. S., Tan, E. S. J., Chan, S. P., Cai, Y., Chong, E. J. Y., Tan, B. Y., Venketasubramanian, N., Hilal, S., Lai, M. K. P., Choi, H., Richards, A. M., Cheng, C. Y., & Chen, C. L. H. (2025). A deep‐learning retinal aging biomarker for cognitive decline and incident dementia. Alzheimer's & Dementia, 21(3). https://doi.org/10.1002/alz.14601

Vancouver

Sim MA, Tham YC, Nusinovici S, Quek TC, Yu M, Xue CC, et al. A deep‐learning retinal aging biomarker for cognitive decline and incident dementia. Alzheimer's & Dementia. 2025;21(3). doi:10.1002/alz.14601

BibTeX
@article{Sim2025,
  author = {Sim, Ming Ann and Tham, Yih Chung and Nusinovici, Simon and Quek, Ten Cheer and Yu, Marco and Xue, Can Can and Chee, Miao Li and Peng, Qing Sheng and Tan, Eugene S J and Chan, Siew Pang and Cai, Yuan and Chong, Eddie Jun Yi and Tan, Boon Yeow and Venketasubramanian, Narayanaswamy and Hilal, Saima and Lai, Mitchell K P and Choi, Hyungwon and Richards, Arthur Mark and Cheng, Ching-Yu and Chen, Christopher L H},
  title = {A deep‐learning retinal aging biomarker for cognitive decline and incident dementia},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {3},
  doi = {10.1002/alz.14601}
}
Kostenlos starten →